TEK and multiple sclerosis: In our case–control cohort, one serum protein, angiopoietin-1 receptor (TIE2), showed significantly higher levels in multiple sclerosis patients compared to controls (FDR = 0.04) and remained significant after correction for sex and age (FDR = 0.01) (Supplementary Table 3B).